Central Sensitization Syndromes and Post-Traumatic Stress in Women: Psychological Profile and Intervention
Enrolling by invitationNot applicableNCT07313280
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Central Sensitivity Syndromes (CSSs) are a group of conditions that are highly prevalent, particularly among women, and often occur alongside post-traumatic stress disorder (PTSD). This research project has two aims: Study 1) to investigate the psychological profiles of women with CSS-PTSD comorbidity; and Study 2) to design and evaluate the effectiveness of distinct interventions for each profile identified in Study 1.
Study details
- Official title
- Psychological Profile Associated With the Complexity of Central Sensitization Syndromes, Comorbid With Trauma and Post-Traumatic Stress Disorder in Women: Testing the Effectiveness of a Person-Centered Psychological Intervention
- Conditions
- Posttraumatic Stress Symptom
- Central Sensitization
- Chronic Pain Syndrome
- Interventions
- Behavioral: CSS-PTSD psychological interventions
- Sponsor
- University of Malaga
- Collaborators
- Ministerio de Ciencia e Innovación, Spain
- Start date
- 2025-10-02
- Primary completion
- 2027-07
- Sex
- Female
- Age range
- from 18 Years to 65 Years
- Results posted
- No results posted in this snapshot
- Countries
- Spain
- Total sites listed
- 3
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. being a biological woman. 2. having a medical diagnosis of CSS. 3. scoring \>36 on the Posttraumatic Stress Disorder Checklist for DSM-5, which indicates PTSD in people with chronic pain. 4. having the ability to understand and sign the informed consent form. Exclusion Criteria: 1. having a diagnosis of serious mental illness or neurodegenerative disease. 2. not being fluent in spoken and written Spanish. 3. undergoing treatment for an oncological, degenerative, or terminal disease.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07313280